Trade Summary

3 days ago, Plump Andrew Stewart, serving as President, R&D at TAKEDA PHARMACEUTICAL CO LTD (TAK), sold 19,651 shares at $18.49 per share, for a total transaction value of $363,346.99. Following this transaction, Plump Andrew Stewart now holds 261,656 shares of TAK.

This sale represents a 6.99% decrease in Plump Andrew Stewart's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, August 19, 2026 and publicly disclosed via SEC Form 4 filing on Friday, August 21, 2026 at 4:30 PM ET, 2 days after the trade was made.

TAKEDA PHARMACEUTICAL CO LTD operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.